Latest profit margin for Globus Medical: 17.03% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for GMED is 17.03% as of June 2026. That compares with 13.58% in the prior-year period — up 25.4% year over year. That is above the Healthcare sector average of 13.89%. Investors often review this figure alongside Globus Medical's historical trend and sector peers before judging valuation or financial health.
Over the past year, GMED's profit margin moved from 13.58% to 17.03% — a 25.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Globus Medical's valuation or profitability profile.
Against Healthcare companies, GMED currently prints 17.03% for profit margin, while the sector average sits near 13.89%. That is roughly 22.6% above the sector mean. Large gaps often invite a closer look at Globus Medical's growth, margins, and balance sheet.
Profit Margin shows how effectively Globus Medical converts resources into returns. At 17.03%, GMED may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 13.58% in the prior-year period — up 25.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting GMED's profit margin (17.03%), review year-over-year change from 13.58%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.